Recording of the Annual HIV Primary Care Update 2019 held on April 25, 2019.
Click "Register" to access the recording.
What Every Primary Care Provider Needs to Know about HIV Daniel Skiest, MD, FACP, FIDSA Division of Infectious Diseases Vice Chair for Academic Affairs, Department of Medicine Professor of Medicine, UMMS-Baystate
Pain Management in the Substance Use Population Daniel P. Alford, MD, MPH Professor of Medicine, Associate Dean, Continuing Medical Education Director, CARE Unit Director, SCOPE of Pain Program Boston University School of Medicine / Boston Medical Center
Getting to Zero Among Communities of Color: Dismantling Isms to Get to Zero Chioma Nnaji, MPH, MEd Program Director, Multicultural AIDS Coalition Program Director, UMass Center for Health Equity and Intervention Research (CHEIR)
Panel: Amir Dixon CEO, Creative Director, Amir Now, Inc.
Malkia Kendricks Program Director, Multicultural AIDS Coalition
Elizabeth Sanchez Program Coordinator, Multicultural AIDS Coalition
Health Threats Facing Older Adults Living with HIV Philip Bolduc, MD Faculty Physician Associate Director, Special Populations Family Health Center of Worcester Principal Investigator, NEAETC
STD Update Katherine Hsu, MD, MPH, FAAP Medical Director, Division of STD Prevention & HIV/AIDS Surveillance Director, Ratelle, STD/HIV Prevention
PrEP in Primary Care
Andrew Jorgensen, MD, FACP, FAAP Associate Medical Director Outer Cape Health Services
Kevin Herwig Manager, HIV Biomedical Intervention Programs Community Research Initiative
Christopher Casale, RPh, BA, BS, AAHIVS Director of Pharmacy Outer Cape Health Services
HIV-Associated Neurocognitive Disorders and Sensory Neuropathy Shibani Mukerji, MD, PhD Department of Neurology, MGH
A variety of the listed topics will be discussed at this event.
Harm Reduction/Safe Injection
Pre-exposure prophylaxis (PrEP)
Adult and adolescent antiretroviral treatment
Aging and HIV
Clinical manifestations of HIV disease
HIV diagnosis (i.e. HIV testing)
Linkage to Care
Retention and/or re-engagement in care
Medication-assisted therapy for substance use disorders (i.e. buprenorphine, methadone, and/or naltrexone)
Non-infection comorbidities of HIV and viral hepatitis